Insider Stock Trading History of Almenoff June Sherie


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Almenoff June Sherie since year 2005. The trader's CIK number is 1492647. At the time of this reporting, Almenoff June Sherie is the of Brainstorm Cell Therapeutics Inc. . (stock ticker symbol BCLI). See this page for all insider trading activities at Brainstorm Cell Therapeutics Inc. .

Note that in the past Almenoff June Sherie also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Almenoff June Sherie since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-01-04 BCLI Brainstorm Cell Therapeutics Inc. Buy 1,475 3.39 5,000
2018-08-24 INNT Innovate Biopharmaceuticals, Inc. Buy 1,000 4.90 4,897
2018-08-27 INNT Innovate Biopharmaceuticals, Inc. Buy 400 4.93 1,973
2015-02-06 OHRP Ohr Pharmaceutical Inc Buy 6,000 6.75 40,500
2014-09-02 OHRP Ohr Pharmaceutical Inc Buy 1,000 8.12 8,119
2014-09-03 OHRP Ohr Pharmaceutical Inc Buy 1,200 8.05 9,660
2014-06-26 OHRP Ohr Pharmaceutical Inc Buy 3,200 8.34 26,688
2014-04-08 OHRP Ohr Pharmaceutical Inc Buy 5,500 10.25 56,375
2014-02-04 FURX Furiex Pharmaceuticals, Inc. Option Ex 115,113 12.84 1,477,590
2014-02-04 FURX Furiex Pharmaceuticals, Inc. Sale 115,113 116.42 13,402,031
2012-08-14 FURX Furiex Pharmaceuticals, Inc. Buy 50 18.55 927
2012-08-15 FURX Furiex Pharmaceuticals, Inc. Buy 950 18.68 17,746
2012-05-17 FURX Furiex Pharmaceuticals, Inc. Buy 2,000 14.80 29,600
2011-09-09 FURX Furiex Pharmaceuticals, Inc. Buy 1,000 14.95 14,950

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Almenoff June Sherie ( of Brainstorm Cell Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.